 |
PDBsum entry 5c0c
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
5c0c
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
276 a.a.
|
 |
|
|
|
|
|
|
|
100 a.a.
|
 |
|
|
|
|
|
|
|
200 a.a.
|
 |
|
|
|
|
|
|
|
247 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system
|
 |
|
Title:
|
 |
1e6 tcr in complex with hla-a02 carrying rqfgpdwiva
|
|
Structure:
|
 |
Hla class i histocompatibility antigen, a-2 alpha chain. Chain: a, f. Fragment: unp residues 25-300. Synonym: mhc class i antigen a 2, Hla-a02 heavy chain. Engineered: yes. Beta-2-microglobulin. Chain: b, g. Fragment: unp residues 21-119. Engineered: yes.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: hla-a, hlaa. Expressed in: escherichia coli. Expression_system_taxid: 562. Gene: b2m, cdabp0092, hdcma22p. Synthetic: yes. Expression_system_taxid: 562
|
|
Resolution:
|
 |
|
1.97Å
|
R-factor:
|
0.190
|
R-free:
|
0.227
|
|
|
Authors:
|
 |
P.J.Rizkallah,A.M.Bulek,D.K.Cole,A.K.Sewell
|
|
Key ref:
|
 |
D.K.Cole
et al.
(2016).
Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity.
J Clin Invest,
126,
2191-2204.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
12-Jun-15
|
Release date:
|
04-May-16
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P04439
(1A03_HUMAN) -
HLA class I histocompatibility antigen, A alpha chain from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
365 a.a.
276 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P61769
(B2MG_HUMAN) -
Beta-2-microglobulin from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
119 a.a.
100 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
A0A0B4J271
(TVAL3_HUMAN) -
T cell receptor alpha variable 12-3 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
114 a.a.
200 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P01848
(TCA_HUMAN) -
T cell receptor alpha chain constant from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
140 a.a.
200 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Clin Invest
126:2191-2204
(2016)
|
|
PubMed id:
|
|
|
|
|
| |
|
Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity.
|
|
D.K.Cole,
A.M.Bulek,
G.Dolton,
A.J.Schauenberg,
B.Szomolay,
W.Rittase,
A.Trimby,
P.Jothikumar,
A.Fuller,
A.Skowera,
J.Rossjohn,
C.Zhu,
J.J.Miles,
M.Peakman,
L.Wooldridge,
P.J.Rizkallah,
A.K.Sewell.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The cross-reactivity of T cells with pathogen- and self-derived peptides has
been implicated as a pathway involved in the development of autoimmunity.
However, the mechanisms that allow the clonal T cell antigen receptor (TCR) to
functionally engage multiple peptide-major histocompatibility complexes (pMHC)
are unclear. Here, we studied multiligand discrimination by a human,
preproinsulin reactive, MHC class-I-restricted CD8+ T cell clone (1E6) that can
recognize over 1 million different peptides. We generated high-resolution
structures of the 1E6 TCR bound to 7 altered peptide ligands, including a
pathogen-derived peptide that was an order of magnitude more potent than the
natural self-peptide. Evaluation of these structures demonstrated that binding
was stabilized through a conserved lock-and-key-like minimal binding footprint
that enables 1E6 TCR to tolerate vast numbers of substitutions outside of this
so-called hotspot. Highly potent antigens of the 1E6 TCR engaged with a strong
antipathogen-like binding affinity; this engagement was governed though an
energetic switch from an enthalpically to entropically driven interaction
compared with the natural autoimmune ligand. Together, these data highlight how
T cell cross-reactivity with pathogen-derived antigens might break
self-tolerance to induce autoimmune disease.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
| | |